Virginie Bernier
Affiliations: | Biochemistry and Molecular Medicine | Université de Montréal, Montréal, Canada |
Google:
"Virginie Bernier"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bockenhauer D, Carpentier E, Rochdi D, et al. (2010) Vasopressin type 2 receptor V88M mutation: molecular basis of partial and complete nephrogenic diabetes insipidus. Nephron. Physiology. 114: p1-10 |
| Bernier V, Stocco R, Bogusky MJ, et al. (2006) Structure-function relationships in the neuropeptide S receptor: molecular consequences of the asthma-associated mutation N107I. The Journal of Biological Chemistry. 281: 24704-12 |
| Bernier V, Morello JP, Zarruk A, et al. (2006) Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus. Journal of the American Society of Nephrology : Jasn. 17: 232-43 |
| Bernier V, Bichet DG, Bouvier M. (2004) Pharmacological chaperone action on G-protein-coupled receptors. Current Opinion in Pharmacology. 4: 528-33 |
| Bernier V, Lagacé M, Bichet DG, et al. (2004) Pharmacological chaperones: potential treatment for conformational diseases. Trends in Endocrinology and Metabolism: Tem. 15: 222-8 |
| Bernier V, Lagacé M, Lonergan M, et al. (2004) Functional rescue of the constitutively internalized V2 vasopressin receptor mutant R137H by the pharmacological chaperone action of SR49059. Molecular Endocrinology (Baltimore, Md.). 18: 2074-84 |
| Morello JP, Salahpour A, Laperrière A, et al. (2000) Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. The Journal of Clinical Investigation. 105: 887-95 |
| Morello J, Bernier V, Bouvier M, et al. (2000) Des chaperons pharmacologiques pour corriger le diabète insipide néphrogénique ? MéDecine/Sciences. 16: 1109 |